Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +3.79% | 0.00% | -25.54% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.54% | 192M | |
-23.29% | 7.68B | |
+75.58% | 4.31B | |
-2.10% | 2.66B | |
+7.64% | 2.63B | |
-47.96% | 2.11B | |
-16.87% | 1.7B | |
-20.12% | 1.5B | |
+18.29% | 1.16B | |
-44.77% | 1.11B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Canaccord Genuity Adjusts Price Target on Biodesix to $10 From $18, Reiterates Buy Rating